Usana Health Sciences (USNA) Asset Writedowns and Impairment (2010 - 2026)

Usana Health Sciences (USNA) has 6 years of Asset Writedowns and Impairment data on file, last reported at $1.3 million in Q2 2026.

• On a quarterly basis, Asset Writedowns and Impairment rose 7.27% year-over-year to $1.3 million in Q2 2026; TTM through Apr 2026 was $2.8 million, a 27.63% increase from a year earlier, with the FY2026 full-year figure at $2.7 million, up 41.67% from the prior year.
• Asset Writedowns and Impairment for Q2 2026 stood at $1.3 million, up from $264000.0 in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for USNA reached as high as $2.3 million in Q2 2023 and fell as low as -$3.1 million in Q4 2023.
• Historically, Asset Writedowns and Impairment has averaged $451461.5 across 4 years, with a median of $423000.0 in 2023.
• Across the five-year window, Asset Writedowns and Impairment tumbled 59.11% in 2024 and surged 13100.0% in 2026, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at -$3.1 million in 2023, then soared by 100.06% to $2000.0 in 2024, then jumped by 18400.0% to $370000.0 in 2025, then jumped by 251.08% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $1.3 million in Q2 2026, $264000.0 in Q1 2026, and $370000.0 in Q3 2025.